论文信息 - A Phase II Study of Nivolumab or Ipilimumab with or without Azacitidine for Patients with Myelodysplastic Syndrome (MDS) - 字舞流文

A Phase II Study of Nivolumab or Ipilimumab with or without Azacitidine for Patients with Myelodysplastic Syndrome (MDS)

M. Konopleva | S. Colla | H. Kantarjian | G. Garcia-Manero | J. Cortes | K. Patel | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | R. Kanagal-Shamanna | C. Bueso-Ramos | N. Pemmaraju | Hui Yang | Y. Alvarado | K. Sasaki | G. Montalban-Bravo | P. Bose | K. Naqvi | C. Rausch | Yvonne Gasior